EGFR L858R
specificA change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.
18
Centers
12
Active Trials
$2M
Cancer Funding
Top Centers for EGFR L858R(18)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 58.3 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 58.3 |
| 3 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 58.3 |
| 4 | NCI Comprehensive Active Research Program | 58.3 |
| 5 | NCI Comprehensive Active Research Program | 58.3 |
| 6 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 58.3 |
| 7 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 58.3 |
| 8 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 58.3 |
| 9 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 58.3 |
| 10 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 58.3 |
| 11 | Boston University Cancer CenterBoston, MA Active Research Program | 58.3 |
| 12 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 58.3 |
| 13 | NCI Clinical Active Research Program | 54.3 |
| 14 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 52.4 |
| 15 | NCI Comprehensive | 35.8 |
| 16 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 35.8 |
| 17 | Cedars-Sinai CancerLos Angeles, CA | 35.8 |
| 18 | Princess Margaret Cancer CentreToronto, ON | 35.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →